The FDA on Friday approved acellular tissue engineered vessel (Symvess), an off-the-shelf product for treating vascular trauma in the extremities of adults.
The single-use product is surgically implanted for arterial replacement and repair after a traumatic injury to the extremity.
Durham-based Humacyte, founded by three female scientists in 2004, has received marketing approval from the U.S. Food and ...
SYMVESS is a first-in-class bioengineered human tissue designed to be a universally implantable vascular conduit for use in arterial ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback